Cutix Plc (NGX:CUTIX)
3.900
0.00 (0.00%)
At close: Aug 1, 2025
Ligand Pharmaceuticals Balance Sheet
Financials in millions NGN. Fiscal year is May - April.
Millions NGN. Fiscal year is May - Apr.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 | Apr '21 Apr 30, 2021 | 2016 - 2020 |
Cash & Equivalents | 140.9 | 250.72 | 122.42 | 124.64 | 110.58 | Upgrade |
Cash & Short-Term Investments | 140.9 | 250.72 | 122.42 | 124.64 | 110.58 | Upgrade |
Cash Growth | -43.80% | 104.80% | -1.78% | 12.72% | -34.03% | Upgrade |
Accounts Receivable | 355.51 | 91.27 | 226.92 | 260.19 | 60.12 | Upgrade |
Other Receivables | 16.85 | 16.41 | 22.45 | 34.09 | 61.29 | Upgrade |
Receivables | 372.35 | 107.67 | 249.36 | 294.28 | 121.41 | Upgrade |
Inventory | 4,763 | 3,541 | 2,983 | 2,754 | 2,433 | Upgrade |
Prepaid Expenses | 34.5 | 44.84 | 53.62 | 12.35 | 15.31 | Upgrade |
Other Current Assets | 863.2 | 2,003 | 1,304 | 871.66 | 1,106 | Upgrade |
Total Current Assets | 6,174 | 5,947 | 4,713 | 4,057 | 3,787 | Upgrade |
Property, Plant & Equipment | 2,516 | 1,338 | 1,091 | 1,055 | 997.16 | Upgrade |
Other Intangible Assets | - | - | 1.52 | 3.04 | 4.55 | Upgrade |
Other Long-Term Assets | 2.3 | 3.6 | 37.12 | 1.09 | 3.67 | Upgrade |
Total Assets | 8,692 | 7,289 | 5,842 | 5,116 | 4,792 | Upgrade |
Accounts Payable | 757.57 | 407.41 | 340.46 | 348.2 | 131.73 | Upgrade |
Accrued Expenses | 551.33 | 664.91 | 368.18 | 307.36 | 447.93 | Upgrade |
Short-Term Debt | 1,777 | 877.7 | 1,303 | 1,078 | 1,253 | Upgrade |
Current Portion of Long-Term Debt | 336.67 | 336.67 | - | - | 210.4 | Upgrade |
Current Income Taxes Payable | 523.43 | 493.35 | 379.95 | 369.97 | 289.94 | Upgrade |
Other Current Liabilities | 119.3 | 34.23 | 46.32 | 93.47 | 21 | Upgrade |
Total Current Liabilities | 4,065 | 2,814 | 2,438 | 2,197 | 2,354 | Upgrade |
Long-Term Debt | 56.11 | 392.78 | - | - | 81.84 | Upgrade |
Long-Term Deferred Tax Liabilities | 317.57 | 276.74 | 235.92 | 214.27 | 200.85 | Upgrade |
Other Long-Term Liabilities | 0 | 0 | - | -0 | -0 | Upgrade |
Total Liabilities | 4,439 | 3,484 | 2,674 | 2,412 | 2,636 | Upgrade |
Common Stock | 3,523 | 1,761 | 1,761 | 1,761 | 880.66 | Upgrade |
Retained Earnings | 730.22 | 2,044 | 1,407 | 943.13 | 1,275 | Upgrade |
Shareholders' Equity | 4,253 | 3,805 | 3,168 | 2,704 | 2,156 | Upgrade |
Total Liabilities & Equity | 8,692 | 7,289 | 5,842 | 5,116 | 4,792 | Upgrade |
Total Debt | 2,170 | 1,607 | 1,303 | 1,078 | 1,545 | Upgrade |
Net Cash (Debt) | -2,029 | -1,356 | -1,181 | -953.75 | -1,434 | Upgrade |
Net Cash Per Share | -0.29 | -0.19 | -0.17 | -0.14 | -0.20 | Upgrade |
Filing Date Shares Outstanding | 7,045 | 7,045 | 7,045 | 7,045 | 7,045 | Upgrade |
Total Common Shares Outstanding | 7,045 | 7,045 | 7,045 | 7,045 | 7,045 | Upgrade |
Working Capital | 2,108 | 3,133 | 2,275 | 1,860 | 1,433 | Upgrade |
Book Value Per Share | 0.60 | 0.54 | 0.45 | 0.38 | 0.31 | Upgrade |
Tangible Book Value | 4,253 | 3,805 | 3,166 | 2,701 | 2,151 | Upgrade |
Tangible Book Value Per Share | 0.60 | 0.54 | 0.45 | 0.38 | 0.31 | Upgrade |
Land | 205.38 | 205.38 | 205.38 | 205.38 | 205.38 | Upgrade |
Buildings | 575.96 | 575.96 | 575.96 | 467.21 | 460.59 | Upgrade |
Machinery | 2,260 | 2,205 | 1,890 | 1,765 | 1,539 | Upgrade |
Construction In Progress | 1,345 | 69.49 | 32.06 | 21.82 | 6.31 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.